Holdings
DWS Health and Wellness Fund
As of May 31, 2026, DWS Health and Wellness Fund reported 62 positions worth US$231M. Largest: Eli Lilly And Company, Johnson & Johnson and Unitedhealth Group Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 29,054 | US$32.1M | −2,500 | May 31, 2026 |
| Johnson & Johnson | 63,685 | US$14.4M | no change | May 31, 2026 |
| Unitedhealth Group Incorporated | 34,923 | US$13.3M | −7,400 | May 31, 2026 |
| Abbvie Inc. | 52,180 | US$11.4M | no change | May 31, 2026 |
| Merck & Company, Inc. | 94,719 | US$11.2M | no change | May 31, 2026 |
| Astrazeneca Plc | 47,473 | US$8.81M | no change | May 31, 2026 |
| Thermo Fisher Scientific Inc | 16,298 | US$8.03M | no change | May 31, 2026 |
| Novartis Ag | 44,794 | US$6.71M | −177 | May 31, 2026 |
| Amgen Inc. | 19,793 | US$6.67M | no change | May 31, 2026 |
| Gilead Sciences, Inc. | 47,850 | US$6.43M | no change | May 31, 2026 |